"This is a blatant attempt at rent-seeking by an obvious vested interest. We know that the pharmaceutical industry has been lobbying hard to hamper the growth of e-cigarettes so it comes as no surprise to find Glaxo using the tired old gateway argument. The truth is that e-cigarettes will only "seriously disadvantage" the NRT market if they work better as quitting aids. In my experience—and the experience of countless other people—e-cigarettes are much better substitutes for smoking. If they were really a "gateway" to smoking, e-cigarettes would be good for companies like Glaxo as they would create more smokers (NRT companies need there to be smokers just as much as cigarette companies do)."

• The truth is that there are at least 10 published studies that examined the health effects of electronic cigarettes. And this doesn't even include the more than 20 studies in which the chemical constituents of electronic cigarette liquids or vapor have been analyzed using gas chromatography/mass spectrometry.

LAST：factory wholesale in stock manhattan mod clone manhattan mod |NEXT：bud touch pen 510 pen vape slim electronic cigarette